BioSpace News Archive

Business

Cidara Therapeutics Aims to Prevent Future COVID-19/Flu Season ‘Twindemics’

Cidara Therapeutics is hoping that its novel approach to influenza will prevent future “twindemic” double threats like the one we may face this year.

September 17, 2020
·
5 min read
·
Heather McKenzie
Genetown

Finch Closes $90 Million Series D to Advance C. Difficile Infection Product

The company plans to use the funds to advance its lead candidate CP101 for recurrent C. difficile infection through the final stages of clinical development and regulatory submission.

September 17, 2020
·
2 min read
·
Mark Terry
Pharm Country

Vaccinex Collaborates with Merck in HNSCC Study

Vaccinex, a company developing a novel approach to treat both cancer and neurodegenerative disease through the inhibition of SEMA4D, will pair its lead asset with Merck’s vaunted checkpoint inhibitor Keytruda.

September 17, 2020
·
2 min read
·
Alex Keown
Policy

New York Charges J&J with Civil Insurance Fraud in Opioid Industry Probe

Johnson & Johnson has become the next big pharma player to be accused in New York State’s Department of Financial Services opioid industry probe.

September 17, 2020
·
2 min read
·
Heather McKenzie
Drug Development

Exicure Announces Positive Phase Ib Trial Results for Solid Tumor Treatment Cavrotolimod

Exicure announced positive results from its Phase Ib trial evaluating cavrotolimod, its SNA-enabled TLR9 agonist, that is being developed for the treatment of solid tumors, in combination with pembrolizumab.

September 17, 2020
·
3 min read
·
Krystle Vermes
Drug Development

Biopharma Update on the Novel Coronavirus: September 18

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 18, 2020.

September 17, 2020
·
3 min read
·
BioSpace Editorial Staff
Business

BioSpace Movers & Shakers, Sept. 18

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

September 17, 2020
·
11 min read
·
Alex Keown
Genetown

Chiasma’s Octreotide Capsules Could Be Answer to Acromegaly Treatment Burdens

Octreotide, a somatostatin analog, significantly inhibits growth hormone, one of the key drivers of acromegaly.

September 17, 2020
·
4 min read
·
Brandon May
Business

CDC Head and Trump Spar Over COVID-19 Vaccine Timeline

Robert Redfield, director of the U.S. Centers for Disease Control and Prevention, testified yesterday before the U.S. Senate Appropriations subcommittee on labor, health and human services, education and related agencies.

September 17, 2020
·
4 min read
·
Mark Terry
Biotech Bay

A Look at ESMO as Companies Share Oncology Updates

The 2020 virtual meeting of the European Society of Medical Oncology is getting underway and companies are lining up to share information on their latest cancer treatments.

September 17, 2020
·
5 min read
·
Alex Keown